| Code | Description | Claims | Beneficiaries | Total Paid |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
96,776 |
81,530 |
$9.18M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
54,201 |
44,188 |
$8.07M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
68,753 |
60,591 |
$3.58M |
| G0378 |
Hospital observation service, per hour |
18,638 |
14,610 |
$3.28M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
60,646 |
54,225 |
$2.78M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
13,267 |
11,857 |
$2.19M |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
28,273 |
24,914 |
$1.56M |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
10,418 |
5,521 |
$1.30M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
44,908 |
36,803 |
$873K |
| J9271 |
Injection, pembrolizumab, 1 mg |
168 |
106 |
$860K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
2,125 |
1,882 |
$789K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
22,679 |
20,711 |
$764K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
22,074 |
13,263 |
$751K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
1,195 |
1,042 |
$749K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
3,273 |
3,017 |
$694K |
| 70450 |
Computed tomography, head or brain; without contrast material |
15,419 |
13,497 |
$635K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
28,880 |
24,795 |
$615K |
| 80053 |
Comprehensive metabolic panel |
164,798 |
127,635 |
$587K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
3,857 |
3,401 |
$558K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
6,746 |
6,140 |
$524K |
| 90378 |
|
1,284 |
1,016 |
$503K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
45,511 |
30,924 |
$484K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
22,368 |
18,967 |
$460K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
36,472 |
20,997 |
$442K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
23,878 |
22,321 |
$430K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
21,970 |
19,169 |
$428K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
8,113 |
7,382 |
$424K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
5,734 |
5,462 |
$420K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
689 |
657 |
$405K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
21,970 |
19,169 |
$396K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
20,954 |
19,436 |
$386K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
3,521 |
3,120 |
$386K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
164,805 |
123,033 |
$369K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
5,033 |
4,547 |
$367K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
4,284 |
3,834 |
$359K |
| 59025 |
Fetal non-stress test |
10,167 |
7,147 |
$355K |
| 47562 |
|
281 |
250 |
$335K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
4,947 |
4,577 |
$334K |
| 76830 |
Ultrasound, transvaginal |
4,581 |
4,245 |
$321K |
| 58661 |
|
381 |
285 |
$319K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
2,589 |
2,402 |
$316K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
3,825 |
3,525 |
$315K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,741 |
4,432 |
$310K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
5,905 |
2,875 |
$305K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
20,007 |
14,404 |
$289K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
15,256 |
14,050 |
$271K |
| 70496 |
|
1,491 |
1,281 |
$255K |
| 70498 |
|
1,426 |
1,245 |
$252K |
| 84443 |
Thyroid stimulating hormone (TSH) |
39,333 |
34,873 |
$248K |
| 71045 |
Radiologic examination, chest; single view |
44,020 |
37,141 |
$244K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
54,050 |
40,702 |
$226K |
| 64615 |
|
868 |
802 |
$224K |
| 70486 |
|
2,303 |
2,091 |
$214K |
| 77066 |
Tomosynthesis, mammo |
1,536 |
1,489 |
$205K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
1,290 |
1,143 |
$199K |
| J1745 |
Injection, infliximab, excludes biosimilar, 10 mg |
301 |
231 |
$192K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
2,390 |
2,278 |
$182K |
| 77334 |
|
509 |
346 |
$182K |
| 72131 |
|
2,722 |
2,468 |
$181K |
| 95819 |
|
607 |
569 |
$170K |
| 36415 |
Collection of venous blood by venipuncture |
195,621 |
152,298 |
$170K |
| 72141 |
|
1,562 |
1,463 |
$168K |
| 90677 |
|
690 |
662 |
$156K |
| 76801 |
|
3,442 |
2,752 |
$154K |
| 93971 |
|
3,513 |
3,148 |
$152K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
3,971 |
3,243 |
$152K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
1,830 |
1,533 |
$150K |
| 90791 |
Psychiatric diagnostic evaluation |
5,801 |
5,087 |
$150K |
| J2505 |
Injection, pegfilgrastim, 6 mg |
79 |
52 |
$145K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
8,065 |
7,454 |
$143K |
| 0450 |
Emergency room services |
3,119 |
2,801 |
$140K |
| 95816 |
|
544 |
524 |
$139K |
| 80061 |
Lipid panel |
34,808 |
32,046 |
$138K |
| 72128 |
|
1,852 |
1,696 |
$126K |
| 76536 |
|
1,706 |
1,630 |
$126K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
11,033 |
10,150 |
$124K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,947 |
2,636 |
$123K |
| 77386 |
|
687 |
56 |
$123K |
| 71250 |
|
1,624 |
1,534 |
$122K |
| 10060 |
|
1,419 |
1,303 |
$120K |
| 71046 |
Radiologic examination, chest; 2 views |
9,443 |
8,566 |
$111K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
3,488 |
3,124 |
$109K |
| 86900 |
|
12,302 |
10,316 |
$108K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
8,909 |
5,182 |
$105K |
| 36430 |
|
1,397 |
803 |
$105K |
| 84484 |
|
34,951 |
21,046 |
$102K |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
1,388 |
934 |
$101K |
| J1569 |
Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg |
254 |
87 |
$99K |
| 83690 |
|
37,703 |
31,388 |
$95K |
| 76642 |
|
3,018 |
2,441 |
$94K |
| 80074 |
|
2,798 |
2,467 |
$94K |
| 96376 |
|
16,555 |
9,329 |
$94K |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
2,125 |
1,881 |
$90K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
2,956 |
2,709 |
$90K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
6,825 |
5,048 |
$89K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
34,245 |
31,570 |
$87K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
28,815 |
25,069 |
$84K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
4,967 |
4,214 |
$83K |
| 86780 |
|
13,520 |
12,261 |
$81K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
11,665 |
9,639 |
$78K |
| 87660 |
|
9,396 |
8,308 |
$78K |
| 83880 |
|
9,004 |
7,451 |
$78K |
| 70491 |
|
740 |
671 |
$78K |
| 90715 |
|
5,137 |
4,697 |
$77K |
| 87150 |
|
3,966 |
3,505 |
$76K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
63,924 |
31,759 |
$75K |
| 87510 |
|
9,396 |
8,308 |
$73K |
| 87480 |
|
9,396 |
8,308 |
$73K |
| 93970 |
|
1,230 |
1,073 |
$72K |
| 76775 |
|
2,721 |
2,521 |
$71K |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
942 |
901 |
$70K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
33,478 |
25,006 |
$69K |
| 84703 |
|
23,172 |
19,931 |
$66K |
| 12011 |
|
1,563 |
1,439 |
$65K |
| 12001 |
|
1,756 |
1,603 |
$62K |
| 74018 |
|
5,626 |
4,972 |
$62K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
5,454 |
5,223 |
$62K |
| 96415 |
|
3,497 |
1,973 |
$62K |
| J2785 |
Injection, regadenoson, 0.1 mg |
1,823 |
1,597 |
$61K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
6,052 |
5,412 |
$59K |
| Q5103 |
Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg |
110 |
90 |
$58K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
1,471 |
1,289 |
$58K |
| 83970 |
|
2,586 |
2,315 |
$58K |
| 73610 |
|
3,792 |
3,341 |
$57K |
| 85027 |
|
33,770 |
26,663 |
$57K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
2,099 |
1,797 |
$55K |
| 73630 |
|
3,782 |
3,290 |
$55K |
| 86480 |
|
1,709 |
1,534 |
$54K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
8,338 |
5,538 |
$53K |
| 96417 |
|
2,834 |
1,467 |
$51K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
189 |
180 |
$50K |
| 73130 |
|
3,244 |
2,767 |
$50K |
| 57265 |
|
67 |
52 |
$49K |
| 73700 |
|
577 |
520 |
$48K |
| 86803 |
|
8,636 |
7,996 |
$48K |
| 84702 |
|
9,081 |
6,819 |
$47K |
| 73564 |
|
2,425 |
2,071 |
$47K |
| 73030 |
|
3,877 |
3,274 |
$47K |
| 97602 |
|
2,977 |
1,601 |
$45K |
| 72100 |
|
3,053 |
2,791 |
$45K |
| 87186 |
|
12,608 |
9,994 |
$45K |
| 87040 |
|
14,928 |
7,450 |
$45K |
| 84403 |
|
2,613 |
2,391 |
$43K |
| 83605 |
|
13,770 |
9,463 |
$43K |
| 73110 |
|
2,374 |
2,066 |
$42K |
| 74183 |
|
153 |
144 |
$41K |
| 87077 |
|
17,919 |
12,971 |
$41K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
29,464 |
23,553 |
$40K |
| 90686 |
|
9,560 |
8,941 |
$40K |
| 76870 |
|
1,232 |
1,114 |
$40K |
| 81001 |
|
37,446 |
32,117 |
$39K |
| 77065 |
Tomosynthesis, mammo |
403 |
367 |
$38K |
| 87070 |
|
9,926 |
8,548 |
$38K |
| 84439 |
|
18,802 |
16,643 |
$36K |
| 82607 |
|
9,182 |
8,311 |
$36K |
| 82728 |
|
8,327 |
7,350 |
$36K |
| 97597 |
|
3,577 |
1,888 |
$36K |
| 96367 |
|
4,567 |
2,880 |
$35K |
| 88307 |
|
2,168 |
1,415 |
$34K |
| 73562 |
|
2,124 |
1,709 |
$34K |
| 80050 |
General health panel |
779 |
765 |
$34K |
| 87522 |
Neg quan hep c or qual rna |
1,492 |
1,351 |
$33K |
| 12002 |
|
823 |
760 |
$33K |
| 73221 |
|
242 |
216 |
$32K |
| 29125 |
|
1,085 |
983 |
$32K |
| 93017 |
|
2,758 |
2,454 |
$32K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
20,554 |
18,252 |
$32K |
| 74240 |
|
415 |
403 |
$32K |
| 82077 |
|
7,259 |
6,269 |
$32K |
| 44970 |
|
32 |
29 |
$31K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
52 |
51 |
$30K |
| 85610 |
|
31,466 |
22,410 |
$29K |
| 77080 |
|
1,599 |
1,568 |
$29K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
332 |
313 |
$29K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
2,116 |
2,031 |
$29K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
894 |
820 |
$29K |
| 0240U |
|
1,973 |
1,789 |
$28K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
411 |
383 |
$28K |
| 72156 |
|
167 |
143 |
$26K |
| J8597 |
Antiemetic drug, oral, not otherwise specified |
17,888 |
15,470 |
$26K |
| 36591 |
|
3,808 |
1,848 |
$26K |
| 83735 |
|
19,960 |
12,991 |
$26K |
| 77412 |
|
233 |
25 |
$26K |
| 74175 |
|
161 |
145 |
$25K |
| 84145 |
|
3,603 |
2,894 |
$25K |
| 86762 |
|
3,968 |
3,639 |
$24K |
| 97165 |
|
1,887 |
1,376 |
$23K |
| 77336 |
|
1,780 |
736 |
$23K |
| Q5121 |
Injection, infliximab-axxq, biosimilar, (avsola), 10 mg |
119 |
95 |
$22K |
| 73080 |
|
1,341 |
1,224 |
$22K |
| 85730 |
|
14,753 |
12,461 |
$22K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,653 |
1,009 |
$22K |
| 73590 |
|
1,953 |
1,608 |
$22K |
| 97161 |
|
1,772 |
1,285 |
$22K |
| 99152 |
|
3,088 |
2,401 |
$21K |
| 81025 |
|
11,340 |
9,984 |
$21K |
| 87340 |
|
5,885 |
5,395 |
$21K |
| 72040 |
|
1,467 |
1,324 |
$21K |
| 83013 |
|
475 |
453 |
$20K |
| 72110 |
|
781 |
738 |
$20K |
| 99070 |
|
1,246 |
702 |
$20K |
| 86235 |
|
1,017 |
493 |
$20K |
| 73090 |
|
1,480 |
1,257 |
$19K |
| 96409 |
|
341 |
137 |
$19K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
12,758 |
9,043 |
$19K |
| 97162 |
|
1,292 |
999 |
$19K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,839 |
2,254 |
$19K |
| 86140 |
|
12,073 |
10,030 |
$19K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
818 |
643 |
$19K |
| 85379 |
|
5,353 |
4,734 |
$18K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
36,290 |
21,584 |
$18K |
| 73140 |
|
976 |
886 |
$18K |
| 72170 |
|
1,652 |
1,445 |
$17K |
| 94010 |
|
530 |
480 |
$16K |
| 94060 |
|
418 |
404 |
$16K |
| 72158 |
|
78 |
77 |
$16K |
| 84481 |
|
2,184 |
2,028 |
$16K |
| 82746 |
|
5,126 |
4,630 |
$16K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,905 |
2,704 |
$16K |
| 86850 |
|
12,002 |
10,114 |
$16K |
| 81003 |
|
21,430 |
18,876 |
$16K |
| J3490 |
Unclassified drugs |
10,897 |
7,559 |
$16K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
12,126 |
8,089 |
$16K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
276 |
262 |
$15K |
| 57288 |
|
31 |
26 |
$15K |
| 90732 |
|
358 |
307 |
$15K |
| J9312 |
Injection, rituximab, 10 mg |
38 |
12 |
$15K |
| 84153 |
|
2,139 |
1,990 |
$15K |
| 87081 |
|
4,531 |
4,224 |
$15K |
| 69210 |
|
674 |
594 |
$15K |
| 99199 |
Unlisted special service, procedure or report |
298 |
256 |
$15K |
| 82784 |
|
3,169 |
2,663 |
$14K |
| 82570 |
|
13,200 |
10,849 |
$14K |
| J0897 |
Injection, denosumab, 1 mg |
73 |
52 |
$14K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
373 |
299 |
$14K |
| 81511 |
|
1,257 |
1,161 |
$14K |
| 86901 |
|
15,437 |
12,754 |
$14K |
| 82670 |
|
633 |
595 |
$14K |
| 82962 |
|
30,341 |
11,397 |
$14K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
52,935 |
36,195 |
$13K |
| 94726 |
|
367 |
357 |
$13K |
| 73502 |
|
893 |
804 |
$13K |
| 86003 |
|
422 |
178 |
$13K |
| J1453 |
Injection, fosaprepitant, 1 mg |
1,165 |
580 |
$13K |
| 73560 |
|
1,168 |
912 |
$12K |
| 83550 |
|
7,609 |
6,850 |
$12K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
32,584 |
22,657 |
$12K |
| 84146 |
|
1,487 |
1,341 |
$12K |
| 74019 |
|
819 |
744 |
$12K |
| 77300 |
|
279 |
231 |
$12K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
9,292 |
6,303 |
$12K |
| 49083 |
|
91 |
40 |
$11K |
| 83540 |
|
8,868 |
7,960 |
$11K |
| 86038 |
|
2,983 |
2,653 |
$11K |
| 96523 |
|
1,279 |
748 |
$10K |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
3,077 |
2,418 |
$10K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
10,981 |
3,677 |
$10K |
| J0295 |
Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm |
4,510 |
1,660 |
$10K |
| 84425 |
|
1,691 |
1,577 |
$10K |
| 84207 |
|
887 |
837 |
$10K |
| 81002 |
|
9,677 |
7,846 |
$10K |
| 83001 |
|
1,489 |
1,382 |
$10K |
| J2704 |
Injection, propofol, 10 mg |
19,087 |
15,750 |
$10K |
| 82043 |
|
7,992 |
7,537 |
$10K |
| 84402 |
|
1,170 |
1,082 |
$9K |
| 83516 |
|
2,720 |
1,780 |
$9K |
| 82803 |
|
1,537 |
1,199 |
$9K |
| 82105 |
|
1,217 |
1,132 |
$9K |
| 83002 |
|
1,301 |
1,207 |
$8K |
| 93922 |
|
272 |
258 |
$8K |
| 97535 |
Self-care/home management training, each 15 minutes |
1,166 |
663 |
$8K |
| 88342 |
|
823 |
647 |
$8K |
| 93880 |
|
160 |
142 |
$8K |
| 11043 |
|
62 |
37 |
$8K |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
2,851 |
2,300 |
$8K |
| 54161 |
|
17 |
12 |
$8K |
| 85055 |
|
1,216 |
749 |
$8K |
| 80081 |
|
161 |
159 |
$8K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
16,985 |
11,792 |
$8K |
| 84270 |
|
1,157 |
1,069 |
$8K |
| 82950 |
|
3,400 |
3,241 |
$8K |
| 85652 |
|
11,371 |
9,418 |
$8K |
| 82274 |
|
1,249 |
1,181 |
$7K |
| 64445 |
|
28 |
27 |
$7K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
6,906 |
4,198 |
$7K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,127 |
1,042 |
$7K |
| 84100 |
|
8,970 |
6,247 |
$7K |
| 85007 |
|
8,098 |
5,887 |
$7K |
| 70487 |
|
71 |
60 |
$7K |
| 99153 |
Mod sedat endo service >5yrs |
1,718 |
1,340 |
$7K |
| 94760 |
|
8,209 |
6,077 |
$7K |
| A4212 |
Non-coring needle or stylet with or without catheter |
6,468 |
3,137 |
$7K |
| 82550 |
|
4,017 |
2,930 |
$7K |
| 94799 |
|
105 |
82 |
$7K |
| 80143 |
|
1,373 |
1,149 |
$7K |
| 95249 |
|
502 |
464 |
$6K |
| 96411 |
|
512 |
262 |
$6K |
| 97166 |
|
463 |
350 |
$6K |
| 87493 |
|
442 |
378 |
$6K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
354 |
298 |
$6K |
| J7050 |
Infusion, normal saline solution, 250 cc |
9,302 |
5,052 |
$6K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
27,255 |
20,132 |
$6K |
| 72197 |
|
18 |
17 |
$6K |
| 80179 |
|
1,178 |
1,063 |
$6K |
| 82140 |
|
1,557 |
1,194 |
$6K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
2,958 |
2,014 |
$6K |
| 82533 |
|
1,246 |
960 |
$5K |
| J2323 |
Injection, natalizumab, 1 mg |
25 |
12 |
$5K |
| 90656 |
|
470 |
467 |
$5K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
12,256 |
8,251 |
$5K |
| 73100 |
|
381 |
308 |
$5K |
| 86376 |
|
1,343 |
1,239 |
$5K |
| 80069 |
|
1,759 |
1,438 |
$5K |
| 73552 |
|
414 |
352 |
$5K |
| 87205 |
|
5,705 |
4,482 |
$5K |
| 86706 |
|
1,551 |
1,374 |
$5K |
| 84156 |
|
5,065 |
4,166 |
$5K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
76 |
67 |
$4K |
| 80076 |
|
1,659 |
1,536 |
$4K |
| 84550 |
|
3,904 |
3,462 |
$4K |
| G0498 |
Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted living) using a portable pump provided by the office/clinic, includes follow up office/clinic visit at the conclusion of the infusion |
199 |
107 |
$4K |
| 72050 |
|
191 |
178 |
$4K |
| 86923 |
|
767 |
372 |
$4K |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
7,628 |
2,675 |
$4K |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
283 |
277 |
$4K |
| 90670 |
|
5,961 |
5,754 |
$4K |
| J1630 |
Injection, haloperidol, up to 5 mg |
4,955 |
3,794 |
$4K |
| 83655 |
|
585 |
547 |
$4K |
| 84252 |
|
611 |
584 |
$4K |
| J3370 |
Injection, vancomycin hcl, 500 mg |
1,905 |
1,091 |
$4K |
| 86800 |
|
1,021 |
920 |
$4K |
| 86704 |
|
1,080 |
973 |
$4K |
| 73620 |
|
374 |
321 |
$4K |
| 89060 |
|
1,093 |
930 |
$4K |
| J2060 |
Injection, lorazepam, 2 mg |
7,444 |
5,531 |
$4K |
| 99406 |
|
791 |
728 |
$4K |
| J1644 |
Injection, heparin sodium, per 1000 units |
8,975 |
3,213 |
$4K |
| 86364 |
|
1,220 |
978 |
$4K |
| 87899 |
|
818 |
536 |
$4K |
| 82330 |
|
1,549 |
1,202 |
$4K |
| 71101 |
|
210 |
195 |
$4K |
| 72070 |
|
239 |
219 |
$4K |
| 86160 |
|
1,518 |
689 |
$4K |
| 88142 |
|
360 |
338 |
$4K |
| 83993 |
|
335 |
312 |
$4K |
| 82010 |
|
1,252 |
974 |
$3K |
| 83525 |
|
791 |
726 |
$3K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
4,778 |
4,136 |
$3K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
11,896 |
4,974 |
$3K |
| 80164 |
|
1,047 |
891 |
$3K |
| 86200 |
|
753 |
685 |
$3K |
| 84480 |
|
1,121 |
1,018 |
$3K |
| 83615 |
|
2,215 |
1,765 |
$3K |
| 77295 |
|
12 |
12 |
$3K |
| T1999 |
Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" |
250 |
170 |
$3K |
| 94729 |
|
386 |
377 |
$3K |
| 82378 |
|
652 |
465 |
$3K |
| 76885 |
|
26 |
25 |
$3K |
| 84112 |
|
424 |
356 |
$3K |
| 88304 |
|
2,435 |
2,033 |
$3K |
| 80055 |
|
107 |
104 |
$3K |
| 95886 |
|
96 |
82 |
$3K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
4,404 |
2,746 |
$3K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
5,203 |
4,145 |
$3K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
309 |
113 |
$3K |
| 88341 |
|
420 |
193 |
$3K |
| 77280 |
|
49 |
25 |
$3K |
| 11045 |
|
263 |
131 |
$3K |
| 72157 |
|
31 |
27 |
$3K |
| 72081 |
|
143 |
138 |
$3K |
| 82951 |
|
409 |
396 |
$3K |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
1,561 |
1,104 |
$3K |
| 78264 |
|
12 |
12 |
$3K |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
4,450 |
2,846 |
$3K |
| 84134 |
|
772 |
675 |
$3K |
| 83520 |
|
687 |
425 |
$3K |
| 86431 |
|
1,847 |
1,642 |
$3K |
| 82731 |
|
163 |
139 |
$3K |
| 0250 |
|
847 |
599 |
$3K |
| 74022 |
|
171 |
158 |
$3K |
| 51798 |
|
796 |
535 |
$3K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
114 |
77 |
$3K |
| 82024 |
|
104 |
96 |
$2K |
| 87807 |
|
415 |
382 |
$2K |
| 73060 |
|
256 |
209 |
$2K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
162 |
95 |
$2K |
| 92250 |
|
59 |
57 |
$2K |
| 73501 |
|
224 |
200 |
$2K |
| 86592 |
|
1,061 |
927 |
$2K |
| 80197 |
|
508 |
305 |
$2K |
| 87529 |
|
137 |
77 |
$2K |
| 87641 |
|
211 |
182 |
$2K |
| 96368 |
|
748 |
350 |
$2K |
| 84466 |
|
706 |
654 |
$2K |
| 86225 |
|
524 |
453 |
$2K |
| 87045 |
|
623 |
565 |
$2K |
| 92610 |
|
89 |
81 |
$2K |
| 82977 |
|
1,275 |
970 |
$2K |
| 12013 |
|
58 |
53 |
$2K |
| 84630 |
|
596 |
557 |
$2K |
| 82565 |
|
2,184 |
1,827 |
$2K |
| 87075 |
|
818 |
601 |
$2K |
| 36592 |
|
110 |
38 |
$2K |
| 85018 |
|
3,208 |
2,336 |
$2K |
| 74181 |
|
13 |
12 |
$2K |
| 82248 |
|
1,229 |
917 |
$2K |
| 85014 |
|
3,184 |
2,380 |
$2K |
| J1750 |
Injection, iron dextran, 50 mg |
12 |
12 |
$2K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
19,505 |
12,742 |
$2K |
| 85046 |
|
1,568 |
1,187 |
$2K |
| 96127 |
|
342 |
305 |
$2K |
| 97802 |
|
140 |
126 |
$2K |
| 73070 |
|
177 |
144 |
$2K |
| 84305 |
|
166 |
153 |
$2K |
| J1940 |
Injection, furosemide, up to 20 mg |
1,489 |
804 |
$2K |
| 72072 |
|
77 |
71 |
$2K |
| 72146 |
|
13 |
13 |
$2K |
| 73521 |
|
66 |
63 |
$2K |
| 82652 |
|
46 |
41 |
$2K |
| 93246 |
|
167 |
161 |
$1K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
63 |
55 |
$1K |
| 86141 |
|
348 |
305 |
$1K |
| 73600 |
|
160 |
131 |
$1K |
| 95250 |
|
13 |
13 |
$1K |
| 87400 |
|
328 |
171 |
$1K |
| J3480 |
Injection, potassium chloride, per 2 meq |
1,623 |
914 |
$1K |
| 96158 |
|
243 |
156 |
$1K |
| 93325 |
|
147 |
131 |
$1K |
| G0008 |
Administration of influenza virus vaccine |
1,420 |
1,161 |
$1K |
| J3360 |
Injection, diazepam, up to 5 mg |
276 |
233 |
$1K |
| 29105 |
|
16 |
12 |
$1K |
| 84165 |
|
578 |
495 |
$1K |
| 87046 |
|
341 |
310 |
$1K |
| J1953 |
Injection, levetiracetam, 10 mg |
291 |
209 |
$1K |
| 82247 |
|
456 |
336 |
$1K |
| 87486 |
|
77 |
69 |
$1K |
| J2274 |
Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg |
746 |
585 |
$1K |
| 99195 |
|
16 |
14 |
$1K |
| 97163 |
|
48 |
41 |
$996.33 |
| 93308 |
|
13 |
13 |
$981.49 |
| 87581 |
|
77 |
69 |
$957.60 |
| 86341 |
|
94 |
57 |
$953.40 |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
1,569 |
1,123 |
$943.87 |
| 82785 |
|
190 |
161 |
$904.22 |
| 87653 |
|
62 |
59 |
$903.98 |
| 89051 |
|
700 |
527 |
$894.97 |
| 84681 |
|
128 |
118 |
$877.64 |
| 86304 |
|
91 |
81 |
$868.91 |
| Q0111 |
Wet mounts, including preparations of vaginal, cervical or skin specimens |
1,351 |
1,223 |
$844.44 |
| 88312 |
|
282 |
230 |
$833.58 |
| 10005 |
|
13 |
12 |
$803.03 |
| J7121 |
5% dextrose in lactated ringers infusion, up to 1000 cc |
241 |
199 |
$792.46 |
| 77073 |
|
26 |
24 |
$728.58 |
| J9190 |
Injection, fluorouracil, 500 mg |
247 |
96 |
$693.14 |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
198 |
186 |
$690.59 |
| 29515 |
|
15 |
14 |
$675.58 |
| 74220 |
|
15 |
14 |
$666.81 |
| C1729 |
Catheter, drainage |
1,044 |
539 |
$660.30 |
| 64400 |
|
16 |
12 |
$629.34 |
| 69209 |
|
77 |
64 |
$613.98 |
| 86258 |
|
253 |
138 |
$601.03 |
| 97605 |
|
49 |
13 |
$551.98 |
| 82952 |
|
305 |
291 |
$546.13 |
| 77077 |
|
18 |
13 |
$536.42 |
| 84460 |
|
346 |
306 |
$520.05 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
2,275 |
1,899 |
$518.62 |
| 99177 |
|
146 |
143 |
$508.11 |
| 77470 |
|
14 |
13 |
$491.50 |
| 87328 |
|
109 |
91 |
$488.03 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
35 |
30 |
$487.56 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
204 |
160 |
$484.45 |
| 87631 |
|
1,789 |
1,584 |
$476.76 |
| C9113 |
Injection, pantoprazole sodium, per vial |
383 |
230 |
$476.06 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
165 |
133 |
$460.84 |
| J3411 |
Injection, thiamine hcl, 100 mg |
215 |
169 |
$447.00 |
| 96159 |
|
153 |
96 |
$443.55 |
| A9541 |
Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries |
29 |
28 |
$433.18 |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
76 |
68 |
$430.91 |
| 86147 |
|
24 |
12 |
$419.51 |
| 51702 |
|
50 |
37 |
$398.58 |
| J2310 |
Injection, naloxone hydrochloride, per 1 mg |
48 |
38 |
$396.84 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
444 |
316 |
$395.33 |
| J9370 |
Vincristine sulfate, 1 mg |
122 |
62 |
$387.72 |
| 73660 |
|
26 |
24 |
$385.80 |
| 87329 |
|
96 |
79 |
$377.61 |
| 84450 |
|
239 |
217 |
$354.34 |
| 70360 |
|
30 |
24 |
$332.47 |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
671 |
473 |
$328.20 |
| J1920 |
Injection, labetalol hydrochloride, 5 mg |
370 |
309 |
$320.70 |
| 0031A |
|
19 |
16 |
$320.04 |
| 86308 |
|
122 |
112 |
$315.43 |
| 85384 |
|
117 |
81 |
$312.58 |
| 88112 |
|
43 |
38 |
$310.68 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
18 |
12 |
$307.86 |
| 82150 |
|
158 |
132 |
$295.57 |
| 84520 |
|
328 |
295 |
$284.98 |
| 80177 |
|
87 |
84 |
$283.12 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
155 |
137 |
$281.52 |
| G0438 |
Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit |
12 |
12 |
$278.41 |
| 82107 |
|
27 |
27 |
$267.08 |
| 70355 |
|
56 |
52 |
$262.35 |
| 88313 |
|
20 |
12 |
$255.15 |
| 83883 |
|
72 |
37 |
$254.23 |
| 83521 |
|
143 |
66 |
$250.07 |
| 87420 |
|
105 |
99 |
$246.28 |
| 73000 |
|
18 |
16 |
$245.52 |
| J0137 |
Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg |
122 |
111 |
$216.80 |
| 90744 |
|
2,787 |
2,713 |
$210.75 |
| 88300 |
|
548 |
468 |
$208.71 |
| 86665 |
|
26 |
12 |
$205.20 |
| 90621 |
|
78 |
78 |
$203.43 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
1,638 |
1,284 |
$203.17 |
| 87102 |
|
109 |
80 |
$200.91 |
| 82627 |
|
26 |
25 |
$196.50 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
287 |
211 |
$190.01 |
| 94664 |
|
65 |
51 |
$185.28 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
41 |
40 |
$185.00 |
| 86039 |
|
59 |
53 |
$175.26 |
| 86162 |
|
12 |
12 |
$162.96 |
| 64447 |
|
45 |
40 |
$161.22 |
| 88360 |
|
25 |
14 |
$158.76 |
| 84155 |
|
518 |
448 |
$157.15 |
| 85347 |
|
136 |
92 |
$156.50 |
| 92558 |
|
144 |
141 |
$149.77 |
| G0475 |
Hiv antigen/antibody, combination assay, screening |
294 |
260 |
$143.56 |
| 90698 |
|
4,307 |
4,190 |
$142.35 |
| 83021 |
|
15 |
13 |
$142.09 |
| 84144 |
|
14 |
13 |
$137.06 |
| 0042T |
|
119 |
95 |
$134.72 |
| 85520 |
|
61 |
38 |
$133.95 |
| 87338 |
|
13 |
13 |
$127.63 |
| 73120 |
|
16 |
13 |
$124.80 |
| 82272 |
|
140 |
115 |
$123.72 |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
1,252 |
593 |
$123.51 |
| 86593 |
|
56 |
51 |
$122.94 |
| C1781 |
Mesh (implantable) |
277 |
249 |
$119.93 |
| 96161 |
|
131 |
127 |
$118.62 |
| 86787 |
|
32 |
25 |
$115.36 |
| J0640 |
Injection, leucovorin calcium, per 50 mg |
56 |
15 |
$111.43 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
75 |
50 |
$109.84 |
| 90662 |
|
712 |
574 |
$102.27 |
| 97116 |
|
40 |
12 |
$100.24 |
| 93280 |
|
12 |
12 |
$99.56 |
| 88302 |
|
312 |
203 |
$96.80 |
| J1815 |
Injection, insulin, per 5 units |
1,062 |
427 |
$91.69 |
| 82040 |
|
206 |
142 |
$90.54 |
| C1769 |
Guide wire |
3,058 |
2,113 |
$80.60 |
| 88720 |
|
27 |
27 |
$79.54 |
| 87076 |
|
61 |
44 |
$77.28 |
| 90710 |
|
1,909 |
1,845 |
$70.05 |
| 85049 |
|
68 |
54 |
$68.18 |
| J7510 |
Prednisolone oral, per 5 mg |
32 |
28 |
$65.56 |
| 82103 |
|
13 |
13 |
$64.19 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
54 |
26 |
$60.51 |
| J2800 |
Injection, methocarbamol, up to 10 ml |
25 |
12 |
$58.80 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
755 |
703 |
$56.08 |
| 80178 |
|
26 |
25 |
$55.75 |
| 84132 |
|
191 |
125 |
$50.24 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
98 |
54 |
$47.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
19,453 |
17,174 |
$46.23 |
| 84478 |
|
55 |
38 |
$45.79 |
| 90633 |
|
2,654 |
2,577 |
$44.26 |
| 84436 |
|
26 |
25 |
$42.21 |
| 86015 |
|
12 |
12 |
$40.32 |
| 87147 |
|
41 |
26 |
$37.73 |
| 83519 |
|
17 |
14 |
$36.88 |
| 83695 |
|
14 |
12 |
$35.24 |
| 72020 |
|
20 |
13 |
$33.30 |
| A4338 |
Indwelling catheter; foley type, two-way latex with coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each |
381 |
292 |
$33.05 |
| G0009 |
Administration of pneumococcal vaccine |
322 |
274 |
$32.44 |
| A9576 |
Injection, gadoteridol, (prohance multipack), per ml |
747 |
685 |
$30.50 |
| 84300 |
|
31 |
25 |
$26.56 |
| 84160 |
|
75 |
66 |
$24.71 |
| 80047 |
|
55 |
46 |
$23.74 |
| 89055 |
|
13 |
13 |
$23.28 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
13 |
12 |
$22.39 |
| 90723 |
|
128 |
121 |
$22.01 |
| J9263 |
Injection, oxaliplatin, 0.5 mg |
72 |
14 |
$16.49 |
| 81050 |
|
14 |
12 |
$16.40 |
| 83721 |
|
26 |
24 |
$15.69 |
| 0270 |
|
22 |
12 |
$15.56 |
| 94761 |
|
38 |
38 |
$13.53 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
178 |
133 |
$12.81 |
| 88311 |
|
48 |
38 |
$12.51 |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
151 |
145 |
$12.46 |
| A9270 |
Non-covered item or service |
119,849 |
11,272 |
$12.45 |
| J0574 |
Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphine |
14 |
12 |
$11.30 |
| 87015 |
|
13 |
12 |
$9.12 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
1,138 |
764 |
$8.21 |
| J1836 |
Injection, metronidazole, 10 mg |
74 |
50 |
$7.62 |
| J1580 |
Injection, garamycin, gentamicin, up to 80 mg |
51 |
45 |
$7.56 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
84 |
70 |
$5.61 |
| A6403 |
Gauze, non-impregnated, sterile, pad size more than 16 sq. in. less than or equal to 48 sq. in., without adhesive border, each dressing |
56 |
52 |
$4.19 |
| A6402 |
Gauze, non-impregnated, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing |
1,363 |
1,165 |
$3.99 |
| A6454 |
Self-adherent bandage, elastic, non-knitted/non-woven, width greater than or equal to three inches and less than five inches, per yard |
350 |
300 |
$3.96 |
| 90651 |
|
1,095 |
1,061 |
$3.42 |
| 90696 |
|
649 |
626 |
$3.28 |
| 90734 |
|
554 |
529 |
$1.93 |
| 90685 |
|
699 |
677 |
$1.38 |
| 90680 |
|
3,691 |
3,588 |
$1.00 |
| 90707 |
|
191 |
185 |
$0.77 |
| 90716 |
|
186 |
180 |
$0.72 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
536 |
455 |
$0.68 |
| 90700 |
|
853 |
839 |
$0.29 |
| 90648 |
|
704 |
685 |
$0.04 |
| 91303 |
|
17 |
14 |
$0.02 |
| Q0244 |
Injection, casirivimab and imdevimab, 1200 mg |
13 |
12 |
$0.01 |
| 90647 |
|
215 |
206 |
$0.01 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
388 |
311 |
$0.00 |
| 00170 |
Anesthesia for intraoral procedures, including biopsy |
111 |
98 |
$0.00 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
2,009 |
1,525 |
$0.00 |
| G8989 |
Self care functional limitation, discharge status, at discharge from therapy or to end reporting |
90 |
65 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
418 |
324 |
$0.00 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
69 |
60 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
2,602 |
1,890 |
$0.00 |
| 99001 |
|
99 |
94 |
$0.00 |
| A4314 |
Insertion tray with drainage bag with indwelling catheter, foley type, two-way latex with coating (teflon, silicone, silicone elastomer or hydrophilic, etc.) |
34 |
25 |
$0.00 |
| C1771 |
Repair device, urinary, incontinence, with sling graft |
82 |
66 |
$0.00 |
| 95708 |
|
29 |
18 |
$0.00 |
| 91300 |
|
14 |
12 |
$0.00 |
| 01922 |
|
26 |
25 |
$0.00 |
| G8980 |
Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting |
96 |
79 |
$0.00 |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
550 |
518 |
$0.00 |
| G8988 |
Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
304 |
242 |
$0.00 |
| G0472 |
Hepatitis c antibody screening, for individual at high risk and other covered indication(s) |
65 |
62 |
$0.00 |
| A6223 |
Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size more than 16 sq. in., but less than or equal to 48 sq. in., without adhesive border, each dressing |
43 |
39 |
$0.00 |
| G0257 |
Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility |
36 |
17 |
$0.00 |
| A6222 |
Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing |
92 |
73 |
$0.00 |
| A4648 |
Tissue marker, implantable, any type, each |
43 |
38 |
$0.00 |
| 95700 |
|
18 |
16 |
$0.00 |
| G8987 |
Self care functional limitation, current status, at therapy episode outset and at reporting intervals |
299 |
239 |
$0.00 |
| 90697 |
|
77 |
76 |
$0.00 |
| A9585 |
Injection, gadobutrol, 0.1 ml |
61 |
51 |
$0.00 |